Literature DB >> 11997782

Congenital cholesteatoma: 20 years' experience at The Children's Hospital of Philadelphia.

William P Potsic1, S Bruce Korman, Daniel S Samadi, Ralph F Wetmore.   

Abstract

OBJECTIVE: We report our experience with congenital cholesteatoma over a span of 20 years with an emphasis on presenting characteristics and predictors of outcome.
METHODS: We conducted a retrospective review from 1981 through 2000.
RESULTS: One hundred seventy-two congenital cases were identified in 167 patients. Five patients had bilateral disease. The majority (72%) were found in boys, with an average age of 5.0 years. Hearing loss was slight to moderate. When confined to 1 quadrant, cholesteatoma was anterosuperior in 82% of cases; 47% had cholesteatoma in 2 or more quadrants. Ossicular chain involvement was found in 43% of all cases, and mastoid extension was evident in 23%. The rate of recurrent disease was directly related to the extent and number of quadrants involved.
CONCLUSION: To our knowledge, this is the largest series of congenital cholesteatomas to be reported. This review confirms the male predominance and predilection for the anterosuperior quadrant. The extent of cholesteatoma and its relation to residual disease should be used as a guide for planning a second-look procedure.

Entities:  

Mesh:

Year:  2002        PMID: 11997782     DOI: 10.1067/mhn.2002.123446

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  15 in total

1.  Pediatric middle ear cholesteatoma: the comparative study of congenital cholesteatoma and acquired cholesteatoma.

Authors:  Yuka Morita; Yutaka Yamamoto; Shinsuke Oshima; Kuniyuki Takahashi; Sugata Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-05       Impact factor: 2.503

2.  Clinical Characteristics and Treatment Outcomes of Congenital Cholesteatoma.

Authors:  In Sik Song; Won Gue Han; Kang Hyeon Lim; Kuk Jin Nam; Myung Hoon Yoo; Yoon Chan Rah; June Choi
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

3.  Endoscopic visualization to the anterior surface of the malleus and tensor tympani tendon in congenital cholesteatoma.

Authors:  Bong Jik Kim; Jung Ho Kim; Moo Kyun Park; Jun Ho Lee; Seung-Ha Oh; Myung-Whan Suh
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-05       Impact factor: 2.503

4.  Stage progression of congenital cholesteatoma in children.

Authors:  Young Ho Kim; Jae Chul Yoo; Jun Ho Lee; Seung-Ha Oh; Sun O Chang; Ja-Won Koo; Chong Sun Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-06       Impact factor: 2.503

5.  Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.

Authors:  Ewa Olszewska; Jürgen Lautermann; Can Koc; Matthias Schwaab; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-08       Impact factor: 2.503

Review 6.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

7.  [Current aspects of paediatric cholesteatomas].

Authors:  J P Thomas; S Volkenstein; A Minovi; S Dazert
Journal:  HNO       Date:  2013-05       Impact factor: 1.284

8.  Middle ear congenital cholesteatoma: systematic review, meta-analysis and insights on its pathogenesis.

Authors:  Nelson Gilberto; Sara Custódio; Tiago Colaço; Ricardo Santos; Pedro Sousa; Pedro Escada
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-18       Impact factor: 2.503

9.  Epidemiology of middle ear and mastoid cholesteatomas: study of 1146 cases.

Authors:  Jose Evandro Andrade Prudente de Aquino; Nelson Alvares Cruz Filho; Julia Negro Prudente de Aquino
Journal:  Braz J Otorhinolaryngol       Date:  2011-06

Review 10.  Updates and knowledge gaps in cholesteatoma research.

Authors:  Chin-Lung Kuo; An-Suey Shiao; Matthew Yung; Masafumi Sakagami; Holger Sudhoff; Chih-Hung Wang; Chyong-Hsin Hsu; Chiang-Feng Lien
Journal:  Biomed Res Int       Date:  2015-03-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.